Release Kinetics of Copeptin in Patients Undergoing Transcoronary Ablation of Septal Hypertrophy
Open Access
- 1 March 2013
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 59 (3) , 566-569
Abstract
BACKGROUND: The release kinetics of copeptin in patients with acute myocardial infarction (AMI) have been difficult to establish. METHODS: We analyzed the release kinetics of copeptin in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ablation of septal hypertrophy (TASH) as a model of AMI. We included 21 consecutive patients who underwent TASH. Blood samples were collected before and at 15, 30, 45, 60, 75, 90, and 105 min, and at 2, 4, 8, and 24 h after TASH. Serum copeptin was quantified by a sandwich immunoluminometric assay. RESULTS: All patients had copeptin concentrations below the 99th percentile at baseline. The median copeptin concentration was significantly increased at 30 min [16.0 pmol/L; interquartile range (IQR), 13.4–20.2 pmol/L], compared with the median baseline concentration (6.6 pmol/L; IQR, 5.3–8.3 pmol/L; P = 0.002). The copeptin concentration peaked 90 min after induction of myocardial infarction and returned to baseline concentrations (median, 8.2 pmol/L; IQR, 6.3–10.1) after 24 h, compared with the above baseline values (P = 0.06). Serum creatine kinase (CK) activities were significantly increased above baseline values by 1 day after TASH [median maximal postprocedural CK activity, 935.0 U/L (IQR, 545.5–1115.0 U/L); median baseline CK activity, 80.0 U/L (IQR, 63.5–109.0 U/L); P < 0.001]. CONCLUSIONS: Our results provide additional evidence that early rule-out of suspected AMI is possible by using the copeptin concentration in combination with cardiac troponin T.Keywords
Funding Information
- ThermoFisher
This publication has 19 references indexed in Scilit:
- Combined Testing of High-Sensitivity Troponin T and Copeptin on Presentation at Prespecified Cutoffs Improves Rapid Rule-Out of Non–ST-Segment Elevation Myocardial InfarctionClinical Chemistry, 2011
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)European Heart Journal, 2011
- Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndromeAmerican Heart Journal, 2011
- Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarctionEuropean Journal of Clinical Investigation, 2011
- Copeptin: A Biomarker of Cardiovascular and Renal FunctionCongestive Heart Failure, 2010
- Copeptin Improves Early Diagnosis of Acute Myocardial InfarctionJACC, 2010
- Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial InfarctionNew England Journal of Medicine, 2009
- COPEPTIN, A STABLE PEPTIDE OF THE ARGININE VASOPRESSIN PRECURSOR, IS ELEVATED IN HEMORRHAGIC AND SEPTIC SHOCKShock, 2007
- Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of VasopressinClinical Chemistry, 2006
- Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysisJACC, 2000